(Q42165589)

17 October 2017

title

Molecular modeling of protein tyrosine phosphatase 1B (PTP 1B) inhibitors (English)

1 reference

17 October 2017

V Sreenivasa Murthy

1

1 reference

17 October 2017

Vithal M Kulkarni

series ordinal

2

1 reference

17 October 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

Bioorganic & Medicinal Chemistry

17 October 2017

published in

1 reference

17 October 2017

volume

10

1 reference

17 October 2017

issue

4

1 reference

17 October 2017

page(s)

897-906

1 reference

Insulin receptor-associated protein tyrosine phosphatase(s): role in insulin action

17 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900342-X

7 January 2021

Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900342-X

7 January 2021

Osmotic loading of neutralizing antibodies demonstrates a role for protein-tyrosine phosphatase 1B in negative regulation of the insulin action pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900342-X

7 January 2021

Protein-tyrosine phosphatase 1B complexes with the insulin receptor in vivo and is tyrosine-phosphorylated in the presence of insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900342-X

7 January 2021

Skeletal muscle protein tyrosine phosphatase activity and tyrosine phosphatase 1B protein content are associated with insulin action and resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900342-X

7 January 2021

Improved sensitivity to insulin in obese subjects following weight loss is accompanied by reduced protein-tyrosine phosphatases in adipose tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900342-X

7 January 2021

Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900342-X

7 January 2021

Potent Inhibition of Insulin Receptor Dephosphorylation by a Hexamer Peptide Containing the Phosphotyrosyl Mimetic F2Pmp

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900342-X

7 January 2021

An immunological approach reveals biological differences between the two NDF/heregulin receptors, ErbB-3 and ErbB-4.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900342-X

7 January 2021

Phosphonate inhibitors of protein-tyrosine and serine/threonine phosphatases

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900342-X

7 January 2021

Why is phosphonodifluoromethyl phenylalanine a more potent inhibitory moiety than phosphonomethyl phenylalanine toward protein-tyrosine phosphatases?

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900342-X

7 January 2021

The simulated binding of (+/-)-2,3-dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]meth yl] -1H-inden-1-one hydrochloride (E2020) and related inhibitors to free and acylated acetylcholinesterases and corresponding structure-activity analyse

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900342-X

7 January 2021

Modelling study of protein kinase inhibitors: binding mode of staurosporine and origin of the selectivity of CGP 52411

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900342-X

7 January 2021

Understanding the binding of 5-substituted 2'-deoxyuridine substrates to thymidine kinase of herpes simplex virus type-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900342-X

7 January 2021

Selectivity analysis of 5-(arylthio)-2,4-diaminoquinazolines as inhibitors of Candida albicans dihydrofolate reductase by molecular dynamics simulations

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900342-X

7 January 2021

Synthesis and characterization of a novel class of protein tyrosine phosphatase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900342-X

7 January 2021

Novel phosphate mimetics for the design of non-peptidyl inhibitors of protein tyrosine phosphatases

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900342-X

7 January 2021

Protein-tyrosine phosphatases: biological function, structural characteristics, and mechanism of catalysis

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900342-X

7 January 2021

Structure-based discovery of small molecule inhibitors targeted to protein tyrosine phosphatase 1B

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900342-X

7 January 2021

Docking analysis of a series of benzylamino acetylcholinesterase inhibitors with a phthalimide, benzoyl, or indanone moiety

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900342-X

7 January 2021

Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: a paradigm for inhibitor design

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900342-X

7 January 2021

Structural basis for inhibition of the protein tyrosine phosphatase 1B by phosphotyrosine peptide mimetics

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900342-X

7 January 2021

Validation of the general purpose Tripos 5.2 force field

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900342-X

7 January 2021

Refinement of protein conformations using a macromolecular energy minimization procedure

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900342-X

7 January 2021

10.1016/S0968-0896(01)00342-X

Identifiers

DOI

1 reference

release_ewq3c574xzg3rfb64naocnqcuy

17 October 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ewq3c574xzg3rfb64naocnqcuy

24 November 2022

mapped directly with Wikidata item

1 reference